Globus Medical Inc. Class A

67.62+0.0500+0.07%Vol 422.06K1Y Perf 43.69%
Apr 13th, 2021 16:00 DELAYED
BID66.64 ASK68.02
Open67.63 Previous Close67.57
Pre-Market- After-Market67.62
 - -  - -%
Target Price
66.92 
Analyst Rating
Moderate Buy 1.73
Potential %
-1.04 
Finscreener Ranking
★★+     48.74
Insiders Trans % 3/6/12 mo.
-100/-100/-48 
Value Ranking
★★★     51.00
Insiders Value % 3/6/12 mo.
-100/-100/-99 
Growth Ranking
★★★★     62.56
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-99 
Income Ranking
 —    -
Market Cap6.75B 
Earnings Rating
Sell
Price Range Ratio 52W %
97.56 
Earnings Date
6th May 2021

Today's Price Range

66.6567.86

52W Range

42.8568.24

5 Year PE Ratio Range

16.3052.60

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
5.00%
1 Month
8.30%
3 Months
3.95%
6 Months
23.42%
1 Year
43.69%
3 Years
33.48%
5 Years
183.17%
10 Years
-

TickerPriceChg.Chg.%
GMED67.620.05000.07
AAPL134.433.19002.43
GOOG2 267.2712.48000.55
MSFT258.312.40000.94
XOM55.710.21000.38
WFC39.79-0.9800-2.40
JNJ159.48-2.1600-1.34
FB309.76-1.7800-0.57
GE13.44-0.1500-1.10
JPM154.09-1.8600-1.19
Earnings HistoryEstimateReportedSurprise %
Q04 20200.510.5813.73
Q03 20200.310.4958.06
Q02 2020-0.110.07163.64
Q01 20200.400.29-27.50
Q04 20190.520.49-5.77
Q03 20190.430.430.00
Q02 20190.410.410.00
Q01 20190.410.36-12.20
Earnings Per EndEstimateRevision %Trend
3/2021 QR0.36-16.28Negative
6/2021 QR0.42-10.64Negative
12/2021 FY1.84-9.80Negative
12/2022 FY2.13-6.99Negative
Next Report Date6th May 2021
Estimated EPS Next Report0.36
Estimates Count8
EPS Growth Next 5 Years %10.20
Volume Overview
Volume422.06K
Shares Outstanding99.80M
Trades Count5.81K
Dollar Volume46.14M
Avg. Volume472.74K
Avg. Weekly Volume550.51K
Avg. Monthly Volume480.93K
Avg. Quarterly Volume465.58K

Globus Medical Inc. Class A (NYSE: GMED) stock closed at 67.62 per share at the end of the most recent trading day (a 0.07% change compared to the prior day closing price) with a volume of 493.80K shares and market capitalization of 6.75B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 2200 people. Globus Medical Inc. Class A CEO is David M. Demski.

The one-year performance of Globus Medical Inc. Class A stock is 43.69%, while year-to-date (YTD) performance is 3.68%. GMED stock has a five-year performance of 183.17%. Its 52-week range is between 42.85 and 68.24, which gives GMED stock a 52-week price range ratio of 97.56%

Globus Medical Inc. Class A currently has a PE ratio of 66.30, a price-to-book (PB) ratio of 4.39, a price-to-sale (PS) ratio of 11.27, a price to cashflow ratio of 33.70, a PEG ratio of 2.32, a ROA of 6.11%, a ROC of 6.88% and a ROE of 6.74%. The company’s profit margin is 12.72%, its EBITDA margin is 21.20%, and its revenue ttm is $598.47 Million , which makes it $6.00 revenue per share.

Of the last four earnings reports from Globus Medical Inc. Class A, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.36 for the next earnings report. Globus Medical Inc. Class A’s next earnings report date is 06th May 2021.

The consensus rating of Wall Street analysts for Globus Medical Inc. Class A is Moderate Buy (1.73), with a target price of $66.92, which is -1.04% compared to the current price. The earnings rating for Globus Medical Inc. Class A stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Globus Medical Inc. Class A has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Globus Medical Inc. Class A has a Buy technical analysis rating based on Technical Indicators (ADX : 6.08, ATR14 : 1.85, CCI20 : 166.73, Chaikin Money Flow : 0.34, MACD : 0.09, Money Flow Index : 81.17, ROC : 11.42, RSI : 45.99, STOCH (14,3) : 97.18, STOCH RSI : 1.00, UO : 82.78, Williams %R : -2.82), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Globus Medical Inc. Class A in the last 12-months were: Ann D. Rhoads (Sold 0 shares of value $-163 993 ), Daniel T. Scavilla (Sold 0 shares of value $-5 096 500 ), Daniel T. Scavilla (Sold 200 000 shares of value $11 018 000 ), David D. Davidar (Sold 42 000 shares of value $2 520 000 ), David M. Demski (Sold 0 shares of value $-13 631 044 ), David M. Demski (Sold 547 075 shares of value $32 544 657 ), James R. Tobin (Sold 0 shares of value $-604 210 ), James R. Tobin (Sold 23 000 shares of value $1 264 920 ), Kelly G. Huller (Sold 0 shares of value $-362 675 ), Kelly G. Huller (Sold 29 152 shares of value $1 554 492 ), Lemaitre Dan (Sold 0 shares of value $-173 532 ), Lemaitre Dan (Sold 15 384 shares of value $961 039 ), Robert Andrew Douglas (Buy at a value of $199 647)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
7 (63.64 %)
7 (63.64 %)
6 (60.00 %)
Moderate Buy
1 (9.09 %)
1 (9.09 %)
1 (10.00 %)
Hold
2 (18.18 %)
2 (18.18 %)
2 (20.00 %)
Moderate Sell
1 (9.09 %)
1 (9.09 %)
1 (10.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.73
Moderate Buy
1.73
Moderate Buy
1.80

Globus Medical Inc. Class A

Globus Medical is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which includes medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which includes advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.

CEO: David M. Demski

Telephone: +1 610 930-1800

Address: 2560 General Armistead Avenue, Audubon 19403, PA, US

Number of employees: 2 200

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

58%42%

Bearish Bullish

48%52%

Bearish Bullish

64%36%

News

Stocktwits